Advanced Search

Technical Analysis for SAVA - Cassava Sciences, Inc.

Grade Last Price % Change Price Change
grade C 7.02 2.78% 0.19
SAVA closed down 5.14 percent on Wednesday, February 19, 2020, on 19 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
9 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical SAVA trend table...
Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 2.78%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.78%
Lower Bollinger Band Walk Weakness 2.78%
Below Lower BB Weakness 2.78%
Down 3 Days in a Row Weakness 2.78%
Down 4 Days in a Row Weakness 2.78%
Down 5 Days in a Row Weakness 2.78%
Lower Bollinger Band Touch Weakness 2.78%
Oversold Stochastic Weakness 2.78%
1,2,3 Pullback Bullish Bullish Swing Setup -2.50%
Older EOD signals for SAVA ...
View Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
SAVA Chart by TradingView
Basic chart:

Profile

Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
Biology Pain Neuroscience Alzheimer's Disease Psychiatric Diagnosis Psychiatry

Is SAVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Feb 11 S, TMUS among premarket gainers
Feb 11 Cassava Sciences Announces Phase 2a Study of PTI-125 Published in The Journal of Prevention of Alzheimer’s Disease (JPAD)
Jan 28 SDRL, FCEL among premarket gainers
Jan 28 Cassava Sciences Announces Completion of Patient Enrollment of a Phase 2b Study in Alzheimer’s Disease
Jan 19 Cassava Sciences And The Hunt For An Alzheimer's Cure
Jan 15 Cassava Sciences: Alzheimer's Solution Shows Promise After Positive Phase 2a Trial
Jan 14 Cassava Sciences: An Investment Opportunity With Some Volatile Periods But A Net Upside
Jan 14 Heavy Insider Buying On Cassava Sciences Pushes Up The Stock Price
Jan 13 FIVE, EXAS among premarket losers
Jan 10 The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences
See more SAVA news...

Indicators

Indicator Value
52 Week High 10.95
52 Week Low 1.0
Average Volume 6,065,868
200-Day Moving Average 2.49
50-Day Moving Average 6.22
20-Day Moving Average 7.84
10-Day Moving Average 7.72
Average True Range 0.71
ADX 32.88
+DI 26.54
-DI 21.85
Chandelier Exit (Long, 3 ATRs ) 7.63
Chandelier Exit (Short, 3 ATRs ) 8.92
Upper Bollinger Band 8.81
Lower Bollinger Band 6.87
Percent B (%b) -0.02
BandWidth 24.73
MACD Line 0.19
MACD Signal Line 0.47
MACD Histogram -0.2788
Fundamentals Value
Market Cap 45.04 Million
Num Shares 6.59 Million
EPS -2.01
Price-to-Earnings (P/E) Ratio -3.40
Price-to-Sales 0.00
Price-to-Book 2.02
PEG Ratio -0.02
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.48
Resistance 3 (R3) 7.54 7.39 7.37
Resistance 2 (R2) 7.39 7.23 7.36 7.33
Resistance 1 (R1) 7.11 7.12 7.04 7.05 7.30
Pivot Point 6.96 6.96 6.92 6.93 6.96
Support 1 (S1) 6.68 6.80 6.61 6.62 6.36
Support 2 (S2) 6.53 6.69 6.50 6.33
Support 3 (S3) 6.25 6.53 6.29
Support 4 (S4) 6.19